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2Abstract21
Mounting evidence of the effects of endocrine-disrupting chemicals (EDCs) in humans has22
led to assaying a vast array of food items (processed or packaged) as possible sources of human23
exposure to oestrogens. In this study, we investigated the current situation in this respect of24
different food supplements and beer brands. Eleven different food supplements and twenty-four25
beer brands were obtained from Helsinki, Finland. Sample preparation was carried out by26
established methods while oestrogenic activities were assessed by a yeast bioluminiscent assay,27
using two recombinant yeast strains (Saccharomyces cerevisiae BMAEREluc/ERα and S.28
cerevisiae BMA64/luc). All the food supplements as well as 81% of the beer samples tested were29
found to be oestrogenic, with oestradiol equivalent concentrations of food supplements  and beer30
brands ranging from 7.5 to 11.5 µg/ml and from below detection limits to 43.6 ng/ml, respectively.31
The oestrogenic activities detected in beer samples were not dependent on the beer’s alcoholic32
content, country of production, or the size of the production brewery. The results of our study33
imply that both food supplements and beers can be a significant source of human exposure to34
oestrogens. Therefore, further studies and regular surveillance are warranted.35
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4Introduction59
Food supplements are concentrated sources of nutrients or other substances with nutritional60
or physiological effect, whose purpose is to supplement the normal diet. They are originally used61
to correct nutritional deficiencies and to maintain adequate intakes of certain nutrients. In the62
European Union (EU), food supplements are regulated as foods, and the legislation focuses on63
vitamins and minerals used as ingredients in food supplements, thus making the toxicological64
safety of food supplements an inconclusive and somewhat controversial issue. However, food65
supplements have been reported to be of potential public health concern, due to, for example, the66
presence of and/or contamination by endocrine-disrupting chemicals (EDCs), which may be67
natural (such as phytoestrogens) or synthetic. Recent evidence has shown that food supplements68
can be contaminated with low quantities of steroids or stimulants (such as ephedrine) not specified69
on the label. A broad-based investigation of the international nutritional supplement market70
revealed that between 3 to 25% of dietary food supplements were inadvertently or deliberately71
contaminated with steroid hormones [1]. In several studies, the presence of pro-hormones72
(supplements designed to enhance muscle size and strength rapidly) in non-hormonal nutritional73
supplements has been examined. Results from an international study, involving the European74
Union and the United States, showed that 14.8% (94 out of 634 samples) of the investigated non-75
hormonal supplements contained one or more anabolic steroids not declared on the label [2].76
Another source of compounds with hormonal activity in nutritional supplements is plant-77
derived phytoestrogens. At present, controversy remains as to the health impacts of78
phytoestrogens. While epidemiological studies have shown that phytoestrogens (such as genistein)79
may protect against breast cancer and cardiovascular diseases [3] (although genetic composition80
5seems to play a notable role for breast cancer [4]), experimental studies have suggested they could81
enhance the proliferation or metastasis of some types of cancer [5].82
On the other hand, beer is consumed in increasing volumes globally, and has recently83
become more controversial as a source of dietary exposure to oestrogens. The oestrogenic activity84
of beer is due to the presence/use of hops (Humulus lupulus L.) both as a preservative and as a85
flavouring agent in it [6]. The oestrogenic activity of hops was first attributed to xanthohumol86
without convincing evidence [7]. Today, it is known that in addition to xanthohumol, hops also87
contain isoxanthohumol (IX), 6-prenylnaringerin (6-PN) and 8-prenylnaringerin (8-PN) as some88
of its major constituents. The most potent phytoestrogen of them is 8-PN, with its oestrogenic89
activity being equal to, or greater than that of other established plant oestrogens [6].90
Although xanthohumol is the predominant prenylchalcone (prenylated flavonoids found in91
hops and beer) present in beer, most of it is transformed into IX by thermal isomerization during92
wort boiling [8]. IX is further converted to 8-PN in the gastrointestinal tract by the intestinal93
microbe, Eubacterium limosum. Thereby, the human exposure to 8-PN may grow more than 10-94
fold [9]. These observations have led to intense research aiming at deciphering the bioactivities of95
the ultimate metabolite, 8-PN. In vivo, 8-PN showed estrogenic activity [10], inhibited96
angiogenesis [11] and metastasis [12], exhibited antiandrogenic activity [13], as well as prevented97
bone loss in rats [14].98
A number of yeast bioluminescent assays have been developed in recent times to detect the99
presence of endocrine disrupting chemicals in different matrices. However, the yeast100
bioluminescent assay employed in this study uses two recombinant yeast strains (Saccharomyces101
cerevisiae BMAEREluc/ERα and S. cerevisiae BMA64/luc). The yeast strain S. cerevisiae102
BMA64/luc helps to detect the cytotoxic effect of the test compound because it expresses103
6luciferase constitutively, while the human oestrogen receptor–agonist complex is activated in S.104
cerevisiae BMAEREluc/ERα upon binding of an oestrogenic compound, thus resulting in light105
emission. These assays are faster than corresponding colorimetric assays, taking only a few hours106
to be performed.107
To shed more light on these issues, the current study sought to determine the oestrogenic108
activities of a representative selection of food supplements and beer brands marketed in Finland,109
with a view to furthering our understanding of their potential as a source of human exposure to110
oestrogens.111
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7Materials and methods128
Sample collection and preparation129
Food supplements130
Fifteen different food supplements were randomly purchased from a local shop (Prisma, Viikki)131
in Helsinki, Finland. All food supplements investigated were packaged as tablets. Samples were132
prepared for oestrogenic assay by directly dissolving the tablets and capsule in 10 % ethanol. To133
be sure that the 10 % ethanol used as vehicle was not cytotoxic to the yeast, it was used as a134
negative control substance in the yeast bioluminescent assay. All food supplement products were135
readily and completely dissolved in ethanol.136
Beer samples:137
A total of twenty-one different brands of beer and 3 controls (unhoped beer samples) were138
investigated. The selection of beer samples was based on the following grounds: beers produced139
in the two continents with the highest beer consumption (Europe and the USA), beer production140
style (e.g. larger, pilsner, ale, etc.), alcoholic content, brewery size, anticipated oestrogenic141
contents, and hopping style. Our idea was to get an as broad and representative sample of the beer142
brands currently on the market in Finland as possible regarding all these properties.143
Possible oestrogenic compounds in beer samples were extracted by the solid-phase extraction144
method as previously described [15], with the slight modification that 100 ml of the samples were145
first mixed with 25 ml of ethanol (extraction solvent) to increase the extraction efficiency of the146
test system. All beer products mixed readily and completely with ethanol.147
In addition to the different beer brands, Menohop (a product developed using hops for the treatment148
of menopause-related problems in women) was also analysed for comparison.149
8Yeast bioluminescent assay150
The yeast bioluminescent assay was performed as previously described [16]. Briefly, yeast strains151
(S. cerevisiae BMAEREluc/ERα and S. cerevisiae BMA64/luc) were grown overnight until the152
optical density at a wave length of 600 (OD600) reached 0.4 cfu/ml. Necessary dilutions were made,153
and the yeast strains were further grown at 30°C in a shaker for 2.5 hours until OD600 reached154
0.6. Different concentrations of the test compounds, the yeast strains, as well as 10 x luciferin155
solutions were placed in a micro-well-plate and then incubated at 30°C for 2.5 hours before the156
luciferase activity was measured. Oestradiol, genistein and IX served as positive controls, while157
progesterone and testosterone served as negative controls. The data are given as oestradiol (EEQ)158
or genistein equivalents.159
Data analysis160
The fold induction, fold induction corrected (FIC), and limit of detection (LOD) were calculated161
as described previously [17]. Sigmoidal dose–response curves for increasing concentrations of162
oestradiol, genistein and isoxanthohumol were obtained using the software Prisma 5.0 (GraphPad163
software Inc. San Diego, CA). The oestradiol, genistein and IX equivalents of food samples164
showing oestrogenic activity were calculated from probit transformation of the curves.165
166
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9Results and Discussion174
Recent evidence of a decline in male sperm count coupled with increased incidence of175
various types of cancer amongst young men and women [18], as well as of neurobehavioural176
diseases observed in the populations of different countries [19] have led researchers to search for177
possible causes of such inauspicious human conditions. These phenomena have epidemiologically178
been associated with exposure to EDCs, particularly during the intrauterine phase or during critical179
periods of postnatal development [20]. More recently, some food items (including those of plant180
origin) have begun to gain increasing attention as possible sources of human exposure to xeno-181
and phytoestrogens. Thus, our study was aimed at evaluating the current situation of food182
supplements and beers with respect to their oestrogenic activities.183
The oestrogenic activities of food supplements measured are presented in Table 1. All food184
supplements (15) investigated in this study were positive in the yeast bioluminescent assay, with185
their oestradiol and genistein equivalent concentrations ranging from 7.9 to 11.5 µg/ml and 74 to186
240 µg/mg, respectively. These narrow ranges obtained with all samples suggest the presence of a187
common or similar substance/compound in slightly varying concentrations.188
Table 2 shows the oestradiol and IX equivalent concentrations of various brands of189
commercial beer produced in different countries. Seventeen (81%) out of the 21 beer samples190
examined were positive in the test system. The oestradiol and IX equivalent concentrations of the191
tested beer samples were not dependent on their alcohol content, brewery size or country of192
production (Table 2). Beer sample 9 (BS9), with alcoholic content of 4.6% and produced in the193
Netherlands, had the highest oestrogenic activity (43.6 ng/ml EEQ), followed by BS20 (10.5%194
ethanol, produced in Denmark), whose oestrogenic activity was 31.8 ng/ml EEQ. Four (BS3,195
BS12, BS15 and BS19) out of the 21 tested beer samples were negative in the yeast196
10
bioluminescence assay. Although the reason for the low oestrogenicity in these cases is somewhat197
unclear, the outcome was not associated with their alcoholic content or their country of origin198
[Finland (3) and Germany (1)]. Interestingly, all unhoped beer samples (3) used as control in this199
study failed to yield any oestrogenic response, further substantiating the notion that the hop plant200
is the major source of the oestrogenicity in beer.201
IX was previously reported to be non-oestrogenic in a similar yeast bioreporter assay [21].202
Although Milligan et al. [21] did not report the concentration used in that study, we, however,203
found IX to be oestrogenic at concentrations of 1 mg/ml or greater. Below this concentration, IX204
was found to lose its oestrogenic activity. Using phenobarbital-induced rat liver microsomal205
enzyme mix (S9), we therefore investigated the possibility that IX might gain oestrogenicity at206
low concentrations following metabolic activation; however, we failed to find any (data not207
shown). The results of this study thus suggest that IX has relatively weak oestrogenic potency and208
is non-oestrogenic at low concentrations with or without metabolic activation, but it should be kept209
in mind that the rat liver S9 mix may not contain the enzyme activity critical for IX conversion to210
8-PN; i.e. the reaction that takes place in human distal colon [22].211
The oestrogenic activities of beer samples were not unexpected but warrant attention. The212
oestrogenicity of beer is associated with the presence of IX and 8-PN [6], of which 8-PN is an213
exceptionally potent phytoestrogen, being only about 100 times weaker activator of oestrogen214
receptor-α in a yeast reporter-gene assay than oestradiol [23]. Exposure to 8-PN has previously215
been linked to menstrual disturbances in female hop workers [7], and it also reduces hot flushes in216
post-menopausal women. Apart from drugs produced from hops (such as the Menohop used here217
as a positive control), beer consumption is today the only appreciable source of human exposure218
to IX and 8-PN, since hop-picking is now performed mechanically [6]. Although exposure to219
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especially 8-PN has aroused concern due to the high oestrogenic potency of this compound,220
Milligan et al. [6] have argued that the concentrations of IX and 8-PN in beer are not sufficient to221
cause any detrimental health effects. However, Possemiers et al. [22] have contended that intestinal222
conversion of IX upon moderate beer consumption can lead to 8-PN exposure values that might223
fall within the range of human biological activity. It is noteworthy that the highest oestrogenic224
activities of beer brands measured in this study (per l beer) fall only slightly lower than that of225
Menohop (per g), a widely-used hop-based product for the treatment of menopause-related226
problems in women.227
Earlier, Plotan et al. [24] reported that 71–89% of sport supplements exhibited oestrogenic228
activity in an in vitro reporter-gene assay. Some other previous studies have examined isoflavone229
contents and oestrogenic activities in food supplements intended for alleviating menopausal230
complaints in women. One of such products was also included in our study (Menohop in Table 1).231
Reiter et al. [25] reported that only 26.3% (five out of 19) of the high-dose isoflavone preparations232
they analysed contained the isoflavone content or more specified in the package label. Using a233
similar oestrogen receptor-α and reporter gene-based yeast assay to that of ours, they recorded234
oestrogenic activities of up to 200 nmol/g (54 µg/g) EEQ, which is practically equal to the level235
measured by us in the Menohop preparation (Table 1). On the other hand, Andres et al. [26] found236
that the isoflavone supplements they examined contained approximately the amounts of237
isoflavones claimed by the manufacturers in their product information, and the highest oestrogen238
receptor-α–mediated EEQ value (obtained by a human embryonic kidney cell-based reporter-gene239
assay) was 11.6 µg/capsule. Judkins et al. [1] and Geyer et al. [2] have also reported hormonal240
steroid contaminants in various types of food and sport supplements. Interestingly, the241
contaminants were not listed in the packaging material of the supplements, further calling for242
12
serious concern. Controversies exist as to the health impacts of isoflavones. The purported health243
benefits are quite variable in different studies. While isoflavones are reported to lower total244
cholesterol [27], reduce the incidence of breast cancer [28], and diminish the risk of prostate cancer245
[29], they are also known to increase the incidences of goitre and thyroid enlargement in certain246
nutrient-deficient individuals [30].247
In conclusion, the findings imply that food supplements and commercially produced beer248
can be significant sources of human exposure to oestrogens. The oestrogenicity of beer was not249
dependent on the alcoholic content, country of production, or the brewery size. Because of the250
controversy concerning the effects of phytoestrogens on humans, further studies are warranted.251
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Table 1: Oestrogenic activities in different food supplements expressed as oestradiol (EEQ) and348
genistein (GEQ) equivalent concentrations349
Supplement (code) EEQ (μg/ml) GEQ (μg/g)350
FS1 7.9 76351
FS2 11.5 240352
FS3 9.3 110353
FS4 10.7 190354
FS5 7.5 74355
FS6 10.2 170356
FS7 8.4 80357
FS8 7.9 76358
FS9 9.7 140359
FS10 10.9 200360
FS11 10.1 170361
FS12 8.1 79362
FS13 10.7 190363
FS14 10.1 170364
FS15 9.8 140365
Menohop 52.4 (μg/g) NA366
Key: EEQ: Oestradiol equivalent concentration; GEQ: Genistein equivalent concentration; NA:367
Not applicable.368
369
370
371
372
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Table 2: Oestrogenic activities in different beer samples expressed as oestradiol (EEQ) and IX373
(IXEQ) equivalent concentrations374
Beer (code) Country % OH EEQ (ng/ml) IXEQ (mg/ml)375
of376
production377
378
BS1 Finland 4.5 8.4 1.8379
BS2 Finland 4.6 2.3 0.1380
BS3 Finland 4.5 Nil NA381
BS4 USA 5.9 1.0382
BS5 Germany 7.0 1.3383
BS6 Czech Republic 4.4 21.4 4.1384
BS7 Britain 3.5 29.6 4.9385
BS8 Belgium 0.0 2.8 0.2386
BS9 The Netherlands 4.6 43.6 7.4387
BS10 Scotland 5.0 19.8 3.6388
BS11 Mexico 4.5 14.8 2.7389
BS12 Germany 4.7 Nil NA390
BS13 Ireland 4.2 2.8 0.2391
BS14 Finland 5.2 17.4 3.1392
BS15 Finland 7.2 Nil NA393
BS16 Denmark 7.2 10.8 1.1394
BS17 Belgium 9.0 18.4 3.3395
B18 Sweden 5.3 18.2 3.3396
BS19 Finland 7.0 Nil NA397
BS20 Denmark 10.5 31.8 6.4398
BS21 USA 7.3 14.5 2.0399
Control beer 1* Nil Nil Nil400
Control beer 2 Nil Nil Nil401
Control beer 3 Nil Nil Nil402
Key: OH: Alcohol; EEQ: Oestradiol equivalent concentration; IXEQ: IX equivalent concentration; NA; Not403
applicable; * The control beers were made without hops404
405
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Supplementary Table 1: Summary of the characteristics of the beer brands analyzed406
BEER CODE NAME OF BEER COUNTRY PERCENTAGE TYPE OF407
OF ALCOHOL BEER408
PRODUCTION409
410
BS1 Laitilan kukko Finland 4.5 Pils411
BS2 Karhu II Finland 3.5 Lager412
BS3 Koff III Finland 4.5 Lager413
BS4 Budweiser III USA 5.0 Lager414
BS5 Warsteiner P. Germany 0.0 Lager415
BS6 Pilsner Urquell Czech Republic 4.4 Lager416
BS7 Chiswick Britain 3.5 English Bitter417
BS8 Rainbow al. Belgium 0.0 Lager418
BS9 Heineken The Netherlands 4.6 Lager419
BS10 5.A.M. Saint Scotland 5.0 Ale420
BS11 SOL lager Mexico 4.5 Lager421
BS12 Stortebeker Germany 4.7 Pils422
BS13 Guinness-d Ireland 4.2 Stout423
BS14 Prykmestar Finland 5.2 Pils424
BS15 Koff porter Finland 7.2 Porter425
BS16 Carlsberg E Denmark 7.2 Strong Lager426
BS17 Houblon Chouffe Belgium 9.0 Ale427
B18 St. Eriks Sweden 5.3 Lager428
BS19 Beer Hunter’s Finland 7.0 Ale429
BS20 Hr Fredriksen Denmark 10.5 Stout430
BS21 West coast USA 7.3 Ale431
432
